Prolonged exposure to acetaminophen reduces testosterone production by the human fetal testis in a xenograft model
- Authors:
-
- van den Driesche, Sander ;
- Macdonald, Joni ;
- Anderson, Richard A ;
- Johnston, Zoe C ;
- Chetty, Tarini ;
- Smith, Lee B ;
- McKinnell, Chris ;
- Dean, Afshan ;
- Homer, Natalie Z ;
-
Jorgensen, Anne
;
Close
0000-0002-6409-198X
Department of Growth and Reproduction, Juliane Marie Centre, Rigshospitalet, The Capital Region of Denmark - Camacho-Moll, Maria E ;
- Sharpe, Richard M ;
- Mitchell, Rod T
- DOI:
- 10.1126/scitranslmed.aaa4097
- Abstract:
- Most common male reproductive disorders are linked to lower testosterone exposure in fetal life, although the factors responsible for suppressing fetal testosterone remain largely unknown. Protracted use of acetaminophen during pregnancy is associated with increased risk of cryptorchidism in sons, but effects on fetal testosterone production have not been demonstrated. We used a validated xenograft model to expose human fetal testes to clinically relevant doses and regimens of acetaminophen. Exposure to a therapeutic dose of acetaminophen for 7 days significantly reduced plasma testosterone (45% reduction; P = 0.025) and seminal vesicle weight (a biomarker of androgen exposure; 18% reduction; P = 0.005) in castrate host mice bearing human fetal testis xenografts, whereas acetaminophen exposure for just 1 day did not alter either parameter. Plasma acetaminophen concentrations (at 1 hour after the final dose) in exposed host mice were substantially below those reported in humans after a therapeutic oral dose. Subsequent in utero exposure studies in rats indicated that the acetaminophen-induced reduction in testosterone likely results from reduced expression of key steroidogenic enzymes (Cyp11a1, Cyp17a1). Our results suggest that protracted use of acetaminophen (1 week) may suppress fetal testosterone production, which could have adverse consequences. Further studies are required to establish the dose-response and treatment-duration relationships to delineate the maximum dose and treatment period without this adverse effect.
- Type:
- Journal article
- Language:
- English
- Published in:
- Science Translational Medicine, 2015, Vol 7, Issue 288
- Keywords:
- Journal Article; Research Support, Non-U.S. Gov't
- Main Research Area:
- Medical science
- Publication Status:
- Published
- Review type:
- Peer Review
- Submission year:
- 2015
- Scientific Level:
- Scientific
- ID:
- 2265580404
